Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy

Overview of attention for article published in Molecular Diagnosis & Therapy, May 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 4,629 followers.

@LabTestKSA Illustration .. Ali, M.A.M. Mol Diagn Ther (2016) 20: 315. https://t.co/AG0fAklR4U https://t.co/15MvkjKxed

RT @Cord_Blood_News: REVIEW : Chronic Myeloid #Leukemia in the Era of Tyrosine Kinase Inhibitors https://t.co/TiyTquVA7p

REVIEW : Chronic Myeloid #Leukemia in the Era of Tyrosine Kinase Inhibitors https://t.co/TiyTquVA7p

RT @Cord_Blood_News: REVIEW | #Leukemia in the Era of Tyrosine Kinase Inhibitors https://t.co/TiyTquVA7p

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.